Kevin E. Fisher

1.8k citations

47 papers · 1.1k indexed · h-index 17

Co-authors: George E. Davis Wonshill Koh Anastasia Sacharidou Amber N. Stratman W. Brian Saunders DDW Cornelison Kevin Atchison Sarah B. Fisher
Topics: Cancer Genomics and Diagnostics (8 papers)Acute Myeloid Leukemia Research (8 papers)Genetic factors in colorectal cancer (5 papers)
Cited by: Immunology and Allergy Cancer Research Cell Biology
Journals: Blood Cancer The FASEB Journal
Partner nations: United States Germany United Kingdom

In The Last Decade

Kevin E. Fisher

44 papers receiving 1.0k citations

Peers

Countries citing papers authored by Kevin E. Fisher

Since Specialization

Citations

This map shows the geographic impact of Kevin E. Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin E. Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin E. Fisher more than expected).

Fields of papers citing papers by Kevin E. Fisher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin E. Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin E. Fisher. The network helps show where Kevin E. Fisher may publish in the future.

Co-authorship network of co-authors of Kevin E. Fisher

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin E. Fisher. A scholar is included among the top collaborators of Kevin E. Fisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin E. Fisher. Kevin E. Fisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children’s Hospital at Baylor College of Medicine 2024 ·Biomedicines ·Alexandra M. Stevens,(unknown),(unknown),Kevin E. Fisher,Andrea N. Marcogliese,Amos Gaikwad,Pulivarthi H. Rao,(unknown),Michael Krueger,Michael R. Loken,Andrew J. Menssen,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Julia Kim,(unknown),Michele S. Redell	1
2	ALK Fusion in an Adolescent with Acute Myeloid Leukemia: A Case Report and Review of the Literature 2023 ·Biomedicines ·(unknown),(unknown),(unknown),Choladda V. Curry,Kevin E. Fisher,Michele S. Redell	2
3	A Validation Framework for Somatic Copy Number Detection in Targeted Sequencing Panels 2022 ·Journal of Molecular Diagnostics ·Raghu Chandramohan,Jacquelyn Reuther,(unknown),Horatiu Voicu,Karla Alvarez,Sharon E. Plon,Dolores López‐Terrada,Kevin E. Fisher,D. Williams Parsons,Angshumoy Roy	4
4	Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome 2022 ·Cancer Genetics ·(unknown),(unknown),Sarah Scollon,(unknown),Jacquelyn Reuther,(unknown),Ninad Patil,(unknown),Hongzheng Dai,Donna M. Muzny,Richard A. Gibbs,Jennifer L. Bercaw‐Pratt,(unknown),Nino Rainusso,Kevin E. Fisher,Frank Y. Lin,Sharon E. Plon,D. Williams Parsons,Angshumoy Roy	0
5	Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance 2022 ·Haematologica ·Kevin E. Fisher,(unknown),(unknown),(unknown),Jonathan L. Curry,Andrea N. Marcogliese,Angela M. Major,Kala Y. Kamdar,Dolores López‐Terrada,Choladda V. Curry	9
6	Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling 2021 ·JCO Precision Oncology ·(unknown),Jacquelyn Reuther,Kelsey C. Bertrand,Raghu Chandramohan,(unknown),Arnold C. Paulino,Donna M. Muzny,Jianhong Hu,Richard A. Gibbs,Daniel J. Curry,Fatema Malbari,Murali Chintagumpala,Adekunle M. Adesina,Kevin E. Fisher,Stephen C. Mack,Sharon E. Plon,Angshumoy Roy,D. Williams Parsons,Frank Y. Lin	4
7	Successful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitor 2020 ·PubMed ·(unknown),Yulei Shen,(unknown),Jeanne M. Meis,Wei‐Lien Wang,Behrang Amini,Laurence D. Rhines,Jacquelyn Reuther,Angshumoy Roy,Kevin E. Fisher,Anthony P. Conley,J. Andrew Livingston	10
8	Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis 2019 ·Pediatric Hematology and Oncology ·Ting Zhou,(unknown),(unknown),Jacquelyn Reuther,Andrea N. Marcogliese,M. Tarek Elghetany,Angshumoy Roy,Pulivarthi H. Rao,(unknown),Michele S. Redell,(unknown),Choladda V. Curry,Kevin E. Fisher	16
9	Multimodal molecular analysis of an atypical small cell carcinoma of the ovary, hypercalcemic type 2018 ·Molecular Case Studies ·Marjorie David,Rajkumar Venkatramani,(unknown),Angshumoy Roy,Ninad Patil,Kevin E. Fisher	6
10	Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accident 2018 ·Surgery ·Sarah B. Fisher,Gilbert J. Cote,(unknown),Wei Lü,Ximing Tang,Tao Hai,Kevin E. Fisher,Michelle D. Williams,Ignacio I. Wistuba,Steven G. Waguespack,(unknown),Michelle Ludwig,Paul H. Graham,Nancy D. Perrier,Jeffrey E. Lee,Elizabeth G. Grubbs	7
11	Somatic mutations in children with GATA2-associated myelodysplastic syndrome who lack other features of GATA2 deficiency 2017 ·Blood Advances ·Kevin E. Fisher,Amy P. Hsu,Christopher L. Williams,(unknown),(unknown),M. Tarek Elghetany,Steven M. Holland,Alison A. Bertuch,M. Monica Gramatges	25
12	Development and Validation ofCALRMutation Testing for Clinical Diagnosis 2015 ·American Journal of Clinical Pathology ·Cheryl L. Maier,Kevin E. Fisher,(unknown),Charles E. Hill,Karen P. Mann,Linsheng Zhang	7
13	The Role of Immunohistochemical Analysis in the Evaluation of EML4-ALK Gene Rearrangement in Lung Cancer 2014 ·Applied immunohistochemistry & molecular morphology ·Harold C. Sullivan,Kevin E. Fisher,(unknown),Jason Wang,Debra Saxe,Momin T. Siddiqui,(unknown)	15
14	BRAF Mutations in Metastatic Malignant Melanoma 2014 ·Applied immunohistochemistry & molecular morphology ·(unknown),C. M. S. Cohen,Kevin E. Fisher,Momin T. Siddiqui	14
15	The General Surgeon's Quandary: Atypical Lipomatous Tumor vs Lipoma, Who Needs a Surgical Oncologist? 2013 ·Journal of the American College of Surgeons ·Sarah B. Fisher,Katherine J. Baxter,Charles A. Staley,Kevin E. Fisher,David K. Monson,Douglas R. Murray,Shervin V. Oskouei,Sharon W. Weiss,David A. Kooby,Shishir K. Maithel,Keith A. Delman	31
16	Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma 2013 ·Modern Pathology ·Kevin E. Fisher,Qiqin Yin-Goen,(unknown),Joseph S. Sirintrapun,W.T.A. Harrison,R. Benjamin Isett,Michael R. Rossi,Carlos S. Moreno,Andrew N. Young,Adeboye O. Osunkoya	33
17	Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma 2013 ·Journal of Surgical Research ·Kevin E. Fisher,(unknown),Sarah B. Fisher,(unknown),Charles E. Hill,Collin J. Weber,Cynthia Cohen,Jyotirmay Sharma	29
18	Excision repair cross‐complementing gene‐1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter‐1 expression and prognostic value in biliary tract malignancy 2012 ·Cancer ·Sarah B. Fisher,Kevin E. Fisher,Sameer H. Patel,(unknown),David A. Kooby,Bassel F. El‐Rayes,Charles A. Staley,Volkan Adsay,Alton B. Farris,Shishir K. Maithel	28
19	MT1-MMP- and Cdc42-dependent signaling co-regulate cell invasion and tunnel formation in 3D collagen matrices 2009 ·Journal of Cell Science ·Kevin E. Fisher,Anastasia Sacharidou,Amber N. Stratman,(unknown),Sarah B. Fisher,Rachel Mahan,Michael J. Davis,George E. Davis	91
20	Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling 2006 ·Molecular Cancer ·Kevin E. Fisher,(unknown),Wonshill Koh,Nicholas J. Anthis,W. Brian Saunders,George E. Davis	79

About Kevin E. Fisher

Kevin E. Fisher is a scholar working on Hematology, Cancer Research and Genetics, having authored 47 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), Acute Myeloid Leukemia Research (8 papers) and Genetic factors in colorectal cancer (5 papers). The work is most often cited by research in Immunology and Allergy (99 citations), Cancer Research (185 citations) and Cell Biology (183 citations). Kevin E. Fisher has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include George E. Davis, Wonshill Koh, Anastasia Sacharidou, Amber N. Stratman, W. Brian Saunders, DDW Cornelison, Kevin Atchison, Sarah B. Fisher, Ashley L. Siegel and Michael J. Davis. Their work appears in journals such as Blood, Cancer and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact